Stocks
BioMarin Pharmaceutical (BMRN) EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2022 | 2023 | LTM ? | ||||
| EBITDA, bln rub | ? | 48.0 | 165.7 | 267.5 | 310.3 | 114 348 | ||
| Changes by years, y/y, % | -921% | -100% | +61% | +16% | ||||
BioMarin Pharmaceutical. EBITDA US GAAP, bln rub
BioMarin Pharmaceutical. EBITDA US GAAP, changes, %
BioMarin Pharmaceutical. EBITDA US GAAP, sum by quarters, bln rub
BioMarin Pharmaceutical (BMRN) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 109.2 | 136.4 | 162.2 | 113 893 | 156.4 | 114 348 | |
| Changes by years, y/y, % | +26% | +57% | +97% | +160 013% | +120% | |||
| Changes by quarters, q/q, % | +109% | +25% | +19% | +70 129% | -100% | |||
